Literature DB >> 24510303

Animal models of diabetes-induced neuropathic pain.

Corinne A Lee-Kubli1, Teresa Mixcoatl-Zecuatl, Corinne G Jolivalt, Nigel A Calcutt.   

Abstract

Neuropathy will afflict over half of the approximately 350 million people worldwide who currently suffer from diabetes and around one-third of diabetic patients with neuropathy will suffer from painful symptoms that may be spontaneous or stimulus evoked. Diabetes can be induced in rats or mice by genetic, dietary, or chemical means, and there are a variety of well-characterized models of diabetic neuropathy that replicate either type 1 or type 2 diabetes. Diabetic rodents display aspects of sensorimotor dysfunction such as stimulus-evoked allodynia and hyperalgesia that are widely used to model painful neuropathy. This allows investigation of pathogenic mechanisms and development of potential therapeutic interventions that may alleviate established pain or prevent onset of pain.

Entities:  

Year:  2014        PMID: 24510303     DOI: 10.1007/7854_2014_280

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  8 in total

1.  Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.

Authors:  N K Katz; J M Ryals; D E Wright
Journal:  Neuroscience       Date:  2014-11-08       Impact factor: 3.590

Review 2.  Peripheral Neuropathy in Mouse Models of Diabetes.

Authors:  Corinne G Jolivalt; Katie E Frizzi; Lucie Guernsey; Alex Marquez; Joseline Ochoa; Maria Rodriguez; Nigel A Calcutt
Journal:  Curr Protoc Mouse Biol       Date:  2016-09-01

3.  Schwann cells regulate sensory neuron gene expression before and after peripheral nerve injury.

Authors:  Gunnar Poplawski; Tetsuhiro Ishikawa; Coralie Brifault; Corinne Lee-Kubli; Robert Regestam; Kenneth W Henry; Yasuhiro Shiga; HyoJun Kwon; Seiji Ohtori; Steven L Gonias; Wendy M Campana
Journal:  Glia       Date:  2018-03-09       Impact factor: 7.452

4.  Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.

Authors:  Ryan B Griggs; Renee R Donahue; Braxton G Adkins; Katie L Anderson; Olivier Thibault; Bradley K Taylor
Journal:  J Pain       Date:  2015-12-12       Impact factor: 5.820

5.  Resolvin D1: A New Path to Unleash the Analgesic Potential of Peroxisome Proliferator-activated Receptor-γ for Postoperative Pain in Patients with Diabetes.

Authors:  Bradley K Taylor
Journal:  Anesthesiology       Date:  2015-12       Impact factor: 7.892

6.  Sodium nitrate preconditioning prevents progression of the neuropathic pain in streptozotocin-induced diabetes Wistar rats.

Authors:  Hajar Oghbaei; Gisou Mohaddes; GholamReza Hamidian; Rana Keyhanmanesh
Journal:  J Diabetes Metab Disord       Date:  2020-01-13

7.  Beneficial effects of levobupivacaine regional anaesthesia on postoperative opioid induced hyperalgesia in diabetic mice.

Authors:  Anne Gomez-Brouchet; Nelly Blaes; Lionel Mouledous; Olivier Fourcade; Ivan Tack; Bernard Francès; Jean-Pierre Girolami; Vincent Minville
Journal:  J Transl Med       Date:  2015-07-02       Impact factor: 5.531

8.  Methylglyoxal Requires AC1 and TRPA1 to Produce Pain and Spinal Neuron Activation.

Authors:  Ryan B Griggs; Don E Laird; Renee R Donahue; Weisi Fu; Bradley K Taylor
Journal:  Front Neurosci       Date:  2017-12-06       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.